MA H1056 | 2023-2024 | 193rd General Court

Note: Legislation replaced by H4691

Status

Spectrum: Partisan Bill (Republican 7-0)
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-05-30 - Accompanied a study order, see H4691
Text: Latest bill text (Introduced) [PDF]

Summary

Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishing a commission to study maximum allowable costs lists

Sponsors


History

DateChamberAction
2024-05-30HouseAccompanied a study order, see H4691
2023-05-02JointHearing scheduled for 05/16/2023 from 10:00 AM-01:00 PM in A-2 and virtual
2023-02-16SenateSenate concurred
2023-02-16HouseReferred to the Joint Committee on Financial Services

Same As/Similar To

S805 (Similar To) 2024-05-09 - Accompanied a study order, see H4634
H1082 (Similar To) 2024-05-30 - Accompanied a study order, see H4691
S718 (Similar To) 2024-05-09 - Accompanied a study order, see H4634
H4691 (Replaced by) 2024-05-30 - Discharged to the committee on House Rules

Massachusetts State Sources


Bill Comments

feedback